Physician profile
Brett T Quave
NPI 1013911361
$11,691.22
in general payments reported to CMS, 2019-2025
34 companies · $1,271 in 2025
The $1,271 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,408 · 2020: $607 · 2021: $532 · 2022: $3,301 · 2023: $3,258 · 2024: $1,316 · 2025: $1,271.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,293 · Travel and Lodging: $1,551.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,293.26 |
| Travel and Lodging | $1,551.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,758.97 | 2019-2025 | Bionic Navigator, Wavewriter Alpha Prime 16, General - Pain Management |
| Relievant Medsystems, INC. | $1,939.67 | 2021-2023 | Intracept |
| Nalu Medical, INC. | $1,667.52 | 2022-2024 | Nalu Neurostimulation System |
| Pacira Pharmaceuticals Incorporated | $965.76 | 2022 | |
| Saluda Medical Americas, INC. | $608.15 | 2024-2025 | Evoke |
| Medtronic, INC. | $412.70 | 2023-2024 | Intellis Adaptivestim, Synchromedii |
| Collegium Pharmaceutical, INC. | $366.30 | 2019-2024 | Belbuca, Xtampza |
| Medtronic USA, INC. | $307.12 | 2019-2020 | |
| Stimwave Technologies Incorporated | $276.39 | 2019-2021 | |
| Daiichi Sankyo INC. | $249.93 | 2019 | |
| Curonix LLC | $158.16 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Amgen INC. | $96.02 | 2019-2021 | |
| Mml US, INC. | $88.10 | 2025 | Reactiv8 |
| Abbvie INC. | $83.80 | 2022 | |
| Spr Therapeutics, INC | $80.81 | 2024 | Sprint Pns System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Painteq LLC | $79.17 | 2022 | |
| Flowonix Medical Incorporated | $72.95 | 2019 | |
| Pfizer INC. | $69.20 | 2019-2025 | |
| Vertos Medical, INC. | $61.61 | 2023-2024 | Mild Device Kit |
| Allergan, INC. | $50.97 | 2019-2020 | |
| Piramal Critical Care | $30.30 | 2020-2022 | |
| Radius Health, INC. | $30.08 | 2022 | |
| Averitas Pharma INC. | $28.99 | 2024 | Qutenza |
| Biodelivery Sciences International, INC. | $26.67 | 2019-2020 | |
| Antares Pharma, INC. | $23.33 | 2022 | |
| Tersera Therapeutics LLC | $22.50 | 2019 | |
| Impel Pharmaceuticals INC. | $22.01 | 2022 | |
| Abbott Laboratories | $21.74 | 2024 | Proclaim |
| Biohaven Pharmaceutical Holding Company LTD. | $19.56 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $16.73 | 2020 | |
| Bioventus LLC | $15.94 | 2021 | |
| Si-Bone, INC. | $14.95 | 2021 | |
| Saol Therapeutics INC. | $13.62 | 2019 | |
| Mdd US Operations, LLC | $11.50 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brett Quave listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.